Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

LifeStance Health Gr Lowers FY2025 Sales Guidance from $1.400B-$1.440B to $1.140B-$1.430B vs $1.414B Est

Author: Benzinga Newsdesk | November 06, 2025 06:05am
LifeStance Health Gr (NASDAQ:LFST) lowers FY2025 sales outlook from $1.400 billion-$1.440 billion to $1.140 billion-$1.430 billion vs $1.414 billion estimate.

Posted In: LFST

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist